Qu Biologics invited to present research data at inaugural Crohn’s and Colitis Congress
19 déc. 2017 12h45 HE
|
Qu Biologics
VANCOUVER, British Columbia, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...